Charles R. Conway, MD

Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri

  • 6Articles
  • 46KReads
  • 2015–2026Active
  • 56Collaborators
  • 168Citations

About

Charles R. Conway, MD, is affiliated with the Department of Psychiatry at Washington University in St. Louis, Missouri. His publications from 2015 to 2026 focus on treatment-resistant major depressive disorder (MDD) and suicide, including studies on vagus nerve stimulation (VNS) and its effects on suicidal ideation and quality of life. He has also contributed to research on pharmacogenomics and clinical management strategies for treatment-resistant depression. His work frequently involves collaboration with co-authors such as A. John Rush and Scott T. Aaronson.

Publications

JCP
Impact of VNS on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report
Original Research ▶ Video

Impact of VNS on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report

July 8, 2026

Findings suggest that active VNS reduces suicidal ideation (SI) and potentially induces SI remission among participants with chronic TRD and baseline SI.
, , , et al
JCP
Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report
Original Research

Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report

July 14, 2025

History of ECT use (lifetime and current episode) or TMS use (current episode) was prognostic of poorer outcomes across the total sample and superior benefit from active versus sham...
, , , et al
JCP
Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression
Brief Report

Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression

August 16, 2023

In this exploratory analysis, 54% of TRD patients receiving nitrous oxide had a reduction in suicidal ideation, compared with 12% in the placebo group.
, , , et al
JCP
Original Research

Utility of Combinatorial Pharmacogenomics in Depression

October 31, 2019

This study sought to ascertain the extent that pharmacogenetic testing can inform treatment decisions among patients with treatment-resistant depression whose medications are subject to gene-drug interactions—read the article to...
, , , et al
JCP
Original Research

VNS Improves Quality of Life in Depression

August 21, 2018

Vagus nerve stimulation (VNS) treatment has been shown to be efficacious in treatment-resistant depression (TRD). Can VNS treatment lead to improvements in quality of life in patients with TRD...
, , , et al
JCP
Letter to the Editor

Clinical Characteristics and Management of Treatment-Resistant Depression

November 25, 2015

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe